Pfizer Needs AstraZeneca More Than Ever as Generics Increase - Presented by: The Aol. On Network

Pfizer shares are slipping after the drug maker posted first-quarter profits 15 percent lower than a year earlier and revenue down 9 percent. Net income of 57 cents a share beat expectations by 2 cents, but $11.3 billion in sales fell short of analysts' estimates of $12.1 billion. The weaker-than-expected report comes days after its latest offer to purchase British drug maker AstraZeneca for $106 billion was rejected.



Related Videos

Most Popular Videos

Latest Videos